Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach pain and diarrhoea are among the most commonly reported side effects of Mounjaro (tirzepatide), particularly in the first few weeks of treatment or after a dose increase. Clinical trial data show gastrointestinal effects affect a significant proportion of users, usually settling as the body adjusts. These are prescription-only medicines; a prescriber assesses your full medical picture before treatment begins. This page explains what the evidence says, what usually passes on its own, and what needs prompt medical attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults and tracked tirzepatide against placebo over 72 weeks. Across all treatment arms, gastrointestinal events were the most frequently reported side effects: nausea topped the list, followed by diarrhoea, vomiting and constipation. Stomach discomfort and cramping featured consistently. Crucially, most of these events were rated mild to moderate in severity, and the majority occurred around the start of treatment or after a dose step-up rather than persisting throughout. The NHS patient information for tirzepatide lists diarrhoea, stomach pain, indigestion, burping and nausea as common side effects — meaning they affect more than one in ten people taking the medicine. Knowing this in advance matters, because many people who stop treatment early do so in the first few weeks, precisely when these symptoms tend to peak. The evidence is clear that for most, the discomfort is temporary.
If you want a broader picture of how these symptoms sit within Mounjaro's full side-effect profile, our overview of Mounjaro side effects covers each category in detail.
Tirzepatide works on two gut-hormone receptors, GIP and GLP-1, that slow the rate at which the stomach empties. That slowing is part of how it reduces appetite. But it also means the digestive system is doing something genuinely different, and for some people that transition produces cramping, loose stools or a general sense of abdominal unease. The effect tends to be most pronounced in the first one to two weeks at a new dose, then diminishes. A question our prescribers hear most weeks is whether eating before the injection makes a difference, the short answer is that avoiding very large or high-fat meals around injection day, eating smaller portions and staying well-hydrated can all help. Alcohol may worsen GI symptoms and is worth limiting. Moving slowly through the titration schedule, guided by your prescriber, is the most reliable way to keep stomach pain and diarrhoea manageable. Rushing to higher doses before your system has settled almost always makes things worse. For a closer look at diarrhoea specifically, including how long it typically lasts, see our dedicated page on Mounjaro and diarrhoea. If burping accompanies your stomach discomfort, you can read more about how Mounjaro diarrhea and burping often occur together, including why they develop in parallel and what tends to ease both, and our page on sulphur burps and stomach pain on Mounjaro covers why they occur together and what tends to help.
Most abdominal discomfort on tirzepatide is self-limiting. Some symptoms are not. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines confirming that acute pancreatitis is a known, infrequent but potentially serious side effect. The warning sign to act on immediately is severe abdominal pain that does not pass within a few hours and may spread towards the back, with or without vomiting. This is not the usual Mounjaro stomach ache, and our page on Mounjaro side effects and stomach pain explains how to tell the difference between everyday discomfort and symptoms that need urgent attention. Stop eating and seek urgent medical assessment, tell the clinician you are taking tirzepatide. Separately, prolonged diarrhoea carries a real risk of dehydration, which can place strain on the kidneys. If you cannot keep fluids down, are feeling faint or your urine is very dark, seek medical advice that day rather than waiting. Gallbladder problems, including gallstones, are also documented with GLP-1 medicines; right-sided upper abdominal pain or pain spreading to the shoulder after eating warrants a GP call. Any sign of an allergic reaction (swelling of the face, difficulty breathing, widespread rash) is a reason to call 999. Suspected side effects from any medicine can be reported directly at the MHRA's Yellow Card scheme; doing so helps regulators track patterns across the population. For a fuller breakdown of stomach cramp presentations specifically, our page on stomach cramps and diarrhoea on Mounjaro goes further.
At our pharmacy, every Mounjaro consultation is reviewed by a GPhC-registered Independent Prescriber before a prescription is issued. That review covers your existing health conditions, any medicines you already take and factors that might affect how you tolerate the titration. If side effects become difficult to manage between doses, our aftercare team is available seven days a week. We do not auto-renew prescriptions or advance doses without a fresh clinical review, the prescriber reassesses before each repeat order. Mounjaro is a prescription-only medicine, and questions about your individual dose, timing or whether to pause treatment should always go to your prescriber or the Patient Information Leaflet, not a forum. If you are considering treatment and want to understand the full picture, starting with a free consultation is the right first step. Our clinical team, including our clinical lead, takes questions about side effects seriously, checking your eligibility is how that conversation begins.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.